Used as an intermediate in the synthesis of fluorinated pharmaceutical compounds, particularly in the development of selective kinase inhibitors. Its structure supports the creation of bioactive molecules with enhanced metabolic stability and binding affinity. Commonly employed in medicinal chemistry for constructing complex drug candidates targeting neurological and inflammatory disorders. The bromine and amine functionalities allow for further derivatization through cross-coupling and acylation reactions, making it valuable in building diverse compound libraries for drug discovery.